Further analysis indicated that AGBL4-related DEGs like MMP-1, Fos proto-oncogene (FOS), and FosB proto-oncogene (FOSB) are involved in the interleukin (IL)-17 signaling pathway, suggesting that AGBL4 and MMP-1 could influence GBM progression via inflammatory pathways. The gene discussed is MMP1; the disease is glioblastoma.